Zepbound
ProductHeard on podcasts recently
Zepbound is a brand name for tirzepatide, an injectable prescription medication developed by Eli Lilly and Company. It is approved for chronic weight management in adults with obesity or who are overweight with weight-related medical conditions.
Rank this week
—
Not in this week’s list
Share of the conversation
—
Reach this week
—
Tone this week
—
Not enough signal yet (fewer than 3 episodes scored).
Share of the conversation
Mentions of Zepbound per 1,000 mentions of anything, 7-day rolling, all podcasts.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 4 | 0.23‰ | 1 |
| Aug 12 | 0.11‰ | 3 |
| Aug 13 | 0.17‰ | 2 |
| Aug 14 | 0.21‰ | 2 |
| Aug 21 | 0.07‰ | 2 |
| Sep 1 | 0.03‰ | 1 |
| Sep 3 | 0.06‰ | 1 |
| Sep 8 | 0.07‰ | 1 |
| Sep 13 | 0.20‰ | 5 |
| Sep 20 | 0.03‰ | 1 |
| Sep 21 | 0.05‰ | 1 |
| Sep 23 | 0.08‰ | 1 |
| Sep 25 | 0.13‰ | 2 |
| Sep 30 | 0.08‰ | 1 |
| Oct 5 | 0.05‰ | 1 |
Discussed alongside
Names that come up in the same conversations as Zepbound.
Embed this
Paste this on your site to show Zepbound's current trend:
<iframe src="https://podlume.ai/embed/e/work-zepbound" width="360" height="220" style="border:0" loading="lazy" title="Zepbound on PodLume Trends"></iframe>